Brett Matthew Hall - Feb 5, 2025 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Brett Matthew Hall
Stock symbol
IMRX
Transactions as of
Feb 5, 2025
Transactions value $
$0
Form type
4
Date filed
2/7/2025, 04:13 PM
Previous filing
Mar 21, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +240K $0.00 240K Feb 5, 2025 Class A Common Stock 240K $1.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029.